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Aims. To record demographics, symptoms, signs, and laboratory features of confirmed leptospirosis cases in the Hawke’s Bay area
of New Zealand to aid clinicians in diagnosis and recognition of severity.Methods. Review of suspected leptospirosis cases referred
to the reference laboratory from hospitals in the Hawke’s Bay region betweenMarch 2003 andMarch 2012. Inclusion criteria were
IgM positivity and diagnosis confirmed with either polymerase chain reaction (PCR) or microscopic agglutination test (MAT). A
retrospective systematic review of case notes was completed for demographic and laboratory data. Results. Forty-three cases were
included. Most common presenting symptoms were pyrexia (93%), myalgia, and headache (both 86%). 93% of patients worked in
the farming or meat industries. +e most common biochemical abnormalities were elevated CRP (100%) and abnormal urinalysis
(93%). +ere was no difference in disease severity between icteric and anicteric patients. Compared to other studies, patients in
New Zealand have less severe disease. Conclusion. Contrary to popular understanding, this study has not found icteric lep-
tospirosis to be related to more severe disease. Anicteric leptospirosis should be a differential diagnosis in patients presenting with
pyrexia, myalgia, and headache who have elevated CRP and abnormal urinalysis.
1. Introduction
Worldwide, leptospirosis is the most common zoonotic
disease [1]. It has been identified by the World Health
Organization as a neglected disease of increasing importance
[2]. Global incidence rates range dramatically from 0.1-1 per
100,000 per year in temperate climates to 10–100 per 100,000
per year in tropical areas [3].+is may grossly underestimate
incidence in temperate areas, with studies citing leptospi-
rosis as a cause in 20–40% of undifferentiated pyrexia [2, 4].
+is was reiterated in a New Zealand study that diagnosed
leptospirosis in 15% of patients with undifferentiated fever
[5]. In New Zealand, the incidence is 2.5–8.0 per 100,000 per
year, one of the highest rates amongst higher income
countries [6–9].
Leptospirosis is caused by Leptospira spp.—bacteria of
the phylum spirochetes. Infection is caused by contact with
urine of carrier animals via abrasions, mucosal, or close
animal contact. +e main animal reservoirs are rats and
livestock, although domestic animals are also recognised as
carriers. Leptospira spp. survive for 3–7 weeks in contam-
inated environmental fluid reservoirs. Leptospirosis infec-
tion shows seasonal variation with increased transmission
during warmer andmore humid conditions [1, 10]. Infection
risk is associated with occupation through exposure to
animal urine and with recreational activities such as hiking
and watersports [1].
Clinical manifestations range dramatically from a mild,
flu-like illness through to fulminant hepatorenal failure. A
wide spectrum of haemorrhagic complications are reported,
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from mild conjunctival suffusion to pulmonary haemor-
rhage [10].
Infection is identified serologically. Diagnosis in New
Zealand is often through an initial immunological screening
test using enzyme-linked immunosorbent assay (ELISA) for
IgM antibodies. IgM positivity is a useful screening test but
cannot be used to confirm the diagnosis due to cross-
reactivity with other conditions [11]. Confirmatory testing is
undertaken with MATor blood, urine, or CSF PCR [3]. +e
New Zealand Ministry of Health defines a confirmed case as
a four-fold or greater rise between initial and convalescent
samples or a single high antibody titre of >400 in the MAT
[11]. Probable causative serovar is identified by MAT.
Leptospirosis cases may be underreported due to the
nonspecific presentation and often slow diagnostic confir-
mation. However, with worldwide mortality from lepto-
spirosis quoted between 5 and 30%, [3, 10] a high index of
suspicion is required to prevent serious harm. Treatment
with antibiotics remains controversial [12]. It has been
suggested that earlier intervention, often supportive, may
prevent serious sequelae [13, 14].
2. Methods
Ethical approval was granted from New Zealand Health
Research Council (reference 12/02/102).
Data were collected on tests referred to the leptospirosis
reference laboratory from all hospitals in the Hawke’s Bay
region between March 2003 and March 2012 (n� 702). Only
cases with IgM antibody or PCR positivity were included
(n� 179). +ese results were filtered for all confirmed cases,
defined for the purpose of this study as initial MAT >800
(understood to be the national reference level for the
seroprevalence of the area at time of data collection) or four-
fold increase between initial and convalescent samples, or
PCR positivity (n� 43).
Case notes were retrospectively systematically reviewed
for demographic, clinicopathological, and outcome data
(Tables 1–4). Results were compared with previous evidence
from the literature, and icteric and anicteric patients were
compared for features of severity including ICU admission
and need for haemofiltration or vasopressor support. Icterus
was defined as a serum bilirubin of >20 μmol/L.
Formal statistical analysis was not carried out due to the
small sample size.
3. Results
Baseline demographics for the 43 cases included in the study
are shown in Table 1. +e most common occupation was
agriculture, 93% of patients presenting with leptospirosis
worked in farming and meat industries. Patients were
predominantly male (81.4%), of middle age (55.8%), and had
no past medical history.
Most patients (73%) presented first to their GP and 21%
of these had already been initiated on antimicrobial therapy.
On average patients were unwell for six days prior to pre-
sentation (range 2–14 days).
Patients presented with a range of symptoms (Table 2),
the most frequent being fever (93%) followed by headache
and myalgia (both 86%).
+ere were a variety of laboratory sample abnormalities
noted (Table 3). Most frequent was a raised CRP, a non-
specific marker for inflammation. Renal injury was com-
monly reported; 63% of patients had elevated creatinine
values with 30% of patients meeting the definition for acute
kidney injury (AKI, elevation in serum creatinine >1.5 times
baseline). +e majority of patients had abnormal urinalysis
(88% proteinuria and 74% haematuria).
Icterus (serum bilirubin >20 µmol/L) was identified in
40% patients with 60% defined as anicteric. Important
markers of severity have been compared for the two groups
(Table 4). +ere were no cases of fulminant hepatic failure,
death, or requirement for intubation and ventilation. +e
length of hospital stay was similar between the two groups,
but a higher percentage of patients in the anicteric group
required admission to ICU, haemofiltration, and vaso-
pressor support.
At presentation, 35% patients had normal observations,
classified as systolic blood pressure >100mmHg, heart rate
<100 beats per minute, and respiratory rate <20 breaths per
minute. Of the 28% of patients admitted to ICU, only one
had normal observations on admission.
Admission chest radiographs were completed for
eleven (26%) cases. Five were normal. +e remaining
films showed a range of abnormalities with no clear
unifying features: cardiomegaly (n � 1), small areas of
minimal atelectasis (n � 2), increased vascular markings
(n � 1), and peribronchial thickening (n � 2). An elec-
trocardiogram was carried out in ten (23%) cases, re-
ported as normal (n � 3), sinus tachycardia (n � 5), and
atrial fibrillation with fast ventricular response (n � 2).












Mixed New Zealand/European 21 (48.8)
Mixed New Zealand/Maori 13 (30.2)
Mixed New Zealand/Maori/European 1 (2.3)
South East Asian 1 (2.3)
Occupation
Meat freezer worker 7 (16.3)
Home kill contractor 1 (2.3)
Meat processor/worker 20 (46.5)
Farmer/cattle worker 12 (27.9)
Horticultural adviser 1 (2.3)
Plasterer 1 (2.3)
Veterinarian 1 (2.3)
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Table 2: Symptoms and signs reported by patients in comparison with studies in other countries.
Symptom New Zealand 2012 China 1995 [15] (%) Hawaii 1998 [16] (%) Barbados 1990 [17] (%)N� 43 (%) N� 75 N� 353 N� 88
Fever 93 — 99 85
Myalgia 86 100 91 49
Headache 86 89 89 76
Nausea 77 56 77 37
Vomiting 60 51 73 50
Anorexia 60 92 82 85
Rigors 53 — — —
Arthralgia 40 51 59 21
Conjunctival suffusion 40 97 28 54
Photophobia 30 — — 5
Diarrhoea 30 30 53 14
Cough 30 55 — 32
Abdominal pain 26 31 51 43
Sore throat 16 — — 7
Neck stiffness 14 — 27 2
Dyspnoea 12 — — —
Rash 12 0 8 2
Jaundice 9 72 — 95
Sign
Abdominal tenderness 42 — — 25
Oliguria 30 — — 13
Pulmonary crepitations 21 — 17 —
Hepatomegaly 12 — 16 27
Meningism 7 — 27 —
Lymphadenopathy 2 — — 25
Splenomegaly 2 — 4 —
Table 3: Laboratory abnormalities in comparison with Hawaii data [17].
Sample measured Range New Zealand percentage abnormal (%) Hawaii percentage abnormal (%)
WCC — 25 39
Platelet count 77–144 37 58
CRP 80–306 100 —
Creatinine 117–912 63 54
Urea 8–33 56 49
Bilirubin 23–76 40 70
ALT 42–505 67 73
APTT 24–40 33 —
pH 7.23–7.33 37 —
CK 291–430 36 —
Haematuria — 74 72
Proteinuria — 88 54
WCC�white cell count, CRP�C-reactive protein, ALT�alanine aminotransferase, APTT�activated partial thromboplastin time, CK� creatinine kinase.





ICU admission [%] AKI [%] Required haemofiltration [%] Required vasopressor support [%]
Mean Range
Icteric n� 17 4 1–7 4 [23] 5 [29] 0 [0] 3 [18]
Anicteric n� 26 4 1–9 8 [30] 8 [31] 1 [4] 7 [27]
Total n� 43 4 1–9 12 [28] 13 [30] 1 [2] 10 [23]
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All 43 cases were IgM ELISA positive and had their
diagnoses confirmed with either MAT or PCR. Initial MAT
was diagnostic in 4 (9%) of samples; all other sample sets
demonstrated a four-fold increased between initial and
convalescent samples. Of the 26 cases where at least one
sample was sent for PCR testing, 20 (77%) were positive, 12
(60%), 6 (30%), and 2 (10%) on plasma, urine, or both PCRs,
respectively.
Samples were run for serovar (sv) identification in 95%
cases at the reference laboratory, and six different sv were
reported (Figure 1). One sample was negative and two cases
were unable to be determined owing to crossreactivity.+ree
species of Leptospira were reported: Leptospira interrogans
(sv L. australis and L. copenhageni), L. borgpetersenii (sv
L. ballum, L. hardjo, and L. tarrasovi), and L. interrogans (sv
L. australis). +e most common sv seen in this dataset were
L. hardjo and L. pomona.
Most patients received more than one antimicrobial. +e
most common prescriptions were of penicillins (62%) and
doxycycline (57%). When stepping down or changing an-
timicrobial therapy, practitioners most commonly changed
to doxycycline.
4. Discussion
4.1. Demographics. Occupation was the main risk factor for
leptospirosis identified, with 93% of patients working in
farming or meat processing industries. One case was linked
to recreational activities.+e link with the cattle industry is a
consistent finding within studies in New Zealand [9]. +e
national reporting office listed meat processing and agri-
cultural work as responsible for 76.9% of cases [8]. +ese
findings contrast with other high income countries. His-
torically, occupation was the predominant risk factor in the
majority of European cases, but more recent studies suggest
that recreation—most notably watersports—and impov-
erished housing now play equally important roles [18]. In
Germany, 30% of cases were linked to occupational expo-
sure, 30% recreational and 37% residential [18]. In a Ha-
waiian study 41% of cases were occupational and 43%
recreational [16].
Age, gender, and ethnicity in these data mirror the
demographics of the workforce in the agricultural industries
[8]. +e most frequent serovars found in this study are in
keeping with those most frequently isolated from cattle
reservoirs and are consistent with previous epidemiological
studies in New Zealand [6, 8]. L. pomona and L. hardjo are
strongly associated with pigs and cattle, respectively
[6, 8, 10]. +e next most common, L. ballum, is predomi-
nantly associated with rodents, although cattle can act as a
secondary reservoir. +e prevalence of this serovar has been
increasing and may represent contamination of livestock
feed by foraging rodents [6, 19].
4.2. Presentation. Leptospirosis is typically thought to
consist of two phases spanning 7–14 days: an initial febrile
illness followed by an immune phase [1]. In this cohort no
clear biphasic illness was described. However, most patients
had presented to their GP prior to hospital presentation;
thus, the biphasic element may have been missed. +e av-
erage number of days of illness prior to presentation was six
days, fewer than previously observed in other studies.
Patients in this cohort reported a wide range of non-
specific symptoms, in keeping with previous studies
[5, 16, 17]. Compared with data from other countries
[15–17], the most marked difference is that jaundice is much
less frequently observed in New Zealand, 9% compared to
95% and 72% in patients in Barbados [17] and China [15],
respectively. +e unifying features in this cohort were the
presence of fever, high CRP, and abnormal urinalysis.
Headache, myalgia, and nausea were also common. +e
three patients who were apyrexial on admission all devel-
oped pyrexia later in the disease course.
4.3. Myalgia. Myalgia is known as a hallmark of leptospi-
rosis and is typically described as localising to the back and
legs [20, 21]. Histologically, there is focal necrosis of muscle
fibres with a corresponding mild increase in creatinine ki-
nase (CK); rhabdomyolysis is rare [1, 10]. Consistent with
worldwide trends, most patients in this series reported
myalgia that, when specified, commonly affected the back
and legs. Only 36% patients had an elevated CK.
4.4. Headache. Headache is commonly reported in lepto-
spirosis, often described as severe and associated with
vomiting. Patients may present with impaired consciousness
in the early phase followed by meningitic features in the
quarter of cases during the immune phase [1]. Lumbar
puncture may reveal elevated opening pressures and pleo-
cytosis. In this series, headache was a common presentation.
Meningitic features were described in 25% of those reporting
headache, all at presentation and typically nonsevere. +e
mean age of patients reporting headache was 36 years, lower





















































Figure 1: Serovars of leptospira found in the study population.
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consciousness, a late-stage feature of the disease, was absent
in our dataset. +is may be due to earlier presentation to
hospital in this cohort with appropriate supportive treat-
ment reducing the risk of deterioration.
4.5. Ocular. Conjunctival suffusion, particularly when
paired with icteric sclera, has been described as pathogno-
monic for severe leptospirosis or “Weil’s disease” [1]. +e
aetiology of ocular signs is unclear. Although small numbers
of spirochetes are found within the eye during infection,
ocular involvement and uveitis can present after acute in-
fection, suggesting a potential autoimmune cause [1, 10]. In
our sample, there were few patients with ocular symptoms or
signs.
Prospective studies tend to report ocular signs more
frequently than retrospective reviews; there could have been
failure to record the sign rather than lower incidence.
However, a prospective New Zealand study reported low
incidence of ocular signs, [5] suggesting that it may be less
common than in other countries. Given the postulated
autoimmune aetiology, this could be due to host factors
rather than infecting organism.
4.6. Renal andHepatic. Renal dysfunction is the main organ
failure associated with leptospirosis. Histologically, there are
spirochetes in the renal tubules, interstitial nephritis, and
glomerular damage with tubular necrosis [1, 22]. +e aeti-
ology is not fully known, but is likely to be a combination of
direct toxic injury, immune-mediated responses, and cir-
culatory collapse [1, 22, 23]. +ese features impair con-
centrating ability and usually give rise to potassium wasting
[23]. Distinctions have been made between isolated rise in
urea and creatinine and established failure with oliguria, the
former usually recovering without filtration and the latter
often requiring renal replacement therapy [1, 23].
In this case series, renal involvement was almost uni-
versal with 93% of patients having abnormal urinalysis. +is
is consistent with other studies in which 86% of patients had
urine protein excretion of >300mg/day [24] and proteinuria
and pyuria in 67% [20]. Currently, abnormal urinalysis is not
part of the diagnostic criteria for leptospirosis, despite being
a commonly reported feature in many studies. Given the
nonspecific nature of the disease, this represents a useful and
inexpensive diagnostic aid.
Biochemically, 63% of cases in this cohort showed a rise
in creatinine: 30% had AKI, 30% had reduced urine output,
and 33% had hypokalaemia. +ere was no difference be-
tween icteric and anicteric leptospirosis groups regarding
renal dysfunction (50% in each group). +is was in contrast
to previous studies which report jaundice in 80–90% of
patients with AKI [25, 26] and renal dysfunction in only 18%
of nonjaundiced patients [27, 28]. +e combination of
jaundice and AKI in severe leptospirosis has historically
been referred to as Weil’s disease.
Hepatic failure with leptospirosis is rare. Hepatic dys-
function presents with a cholestatic picture and does not
usually involve hepatocyte death [9].+is typically manifests
with a moderate rise in transaminases and ALP and raised
bilirubin. Impaired synthetic function is rare in the absence
of multiorgan failure.
+e frequency of jaundice in this sample was compar-
atively low with 40% of patients icteric versus 72–95% in the
literature [16, 17]. +e presence of jaundice appears to be
independent of any of the serious endpoints of AKI, ICU
admission, requirement for organ support, and length of
hospital stay (Table 4). +is is an important finding as
previously it has been stated that anicteric leptospirosis has
fewer severe consequences than icteric, [1] with icteric
leptospirosis cited as having mortality rates of 5–15% [10].
Our data suggest that risk stratification for patients with
leptospirosis should not be reliant on the presence of icterus.
4.7. Respiratory. Pulmonary involvement in leptospirosis
can be severe and is a strong predictor of mortality
[1, 10, 14, 21]. It is increasingly recognised as a separate
syndrome independent of classically severe leptospirosis, as
it is not consistently related to the presence of jaundice
[10, 20, 21, 28]. Histologically, there are alveolar infiltrates
and haemorrhage suggesting coagulopathy and/or an im-
munological cause [10]. Some studies have reported pul-
monary involvement in nearly 100% of patients while others
report it within the range of 20–70% [1, 10]. In this series
pulmonary symptoms were uncommon, with 30% reporting
cough and 12% shortness of breath. Interestingly, there is
often a disassociation between chest X-ray changes and
reported symptoms [10]. +e small number of cases with
pulmonary involvement in this cohort compared to other
studies may be in part related to genetically determined host
immune responses.
4.8. Haematological. +rombocytopaenia is a common find-
ing in leptospirosis, cited between 50 and 80% [1, 29].+e exact
aetiology is not fully understood; possible causes include direct
bone marrow toxicity or consumption and immune-mediated
response. Derangement of clotting factors has been variably
reported. Whether disseminated intravascular coagulation
(DIC) is present in leptospirosis is debated; it has been shown
inconsistently in animal models but not in humans. +ere is
rarely an effect on fibrinogen, although one study found that
nearly 50%of patients hadDIC [29].+e rate of haemorrhage in
patients with leptospirosis is reported at 23% [29].+e majority
of these are mucosal, although there are reports of clinically
important gastrointestinal and pulmonary haemorrhage [29].
+e presence of thrombocytopaenia is described as an
independent predictor of AKI [1] and mortality [10, 29]. In
this case series, the presence of thrombocytopaenia was
lower than expected at 37%, with no platelet counts less than
50×109/L, compared to quoted values of 50–58% [1, 16].
+ere were only minor derangements in other measures of
coagulation in this population. +is modest derangement
correlates with the lack of pulmonary features and no
documented cases of haemorrhage.
4.9. Cardiovascular. Hypotension is reported in 60% of
patients with leptospirosis [30]. Alongside the classical sepsis
picture of inflammatory vasodilation, myocarditis with
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corresponding reduced cardiac output has been observed in
8% of patients [27, 30]. +is may be compounded by failure
of renal concentrating ability with polyuria as well as
extrarenal losses [24].
In this series, 35% of patients had hypotension (systolic
blood pressure <100mmHg) on admission and 23% re-
quired inotropic support during admission. +e rates of
hypotension and requirement for inotropic support are
lower than other studies and are in keeping with the low
mortality in New Zealand. Two patients had atrial fibrilla-
tion—it is not known if these were pre-existing diagnoses or
new and driven by infection.
4.10. Outcome. Rates of ICU admission were comparatively
low in this cohort, 24% versus 33–64% [31]. Length of
hospital stay was short with a mean and median of four days
and range 1–9 days, lower than comparable health systems
where figures are reported as median 8–10 days and range
1–30 days [31].
+e low mortality from leptospirosis in New Zealand is
in stark contrast to worldwide trends [3]. Factors influencing
this may include that the sv L. icterohaemorrhagiae, iden-
tified as commonly causing severe leptospirosis, was absent
in our series. In our population, features traditionally as-
sociated with higher mortality, such as haemorrhage and
pulmonary involvement, were uncommon.
+e presence of icterus on presentation was not pre-
dictive of outcome. Leptospirosis in New Zealand may
therefore present as a more homogenous illness and clas-
sifying leptospirosis as severe based on the presence of ic-
terus is not justified.+e diagnosis of leptospirosis should be
considered in the absence of jaundice, and both icteric and
anicteric cases were identified and managed promptly in
order to prevent deterioration. +ere may be a role of host
immune genetic responses in explaining the different clinical
picture in this cohort.
4.11. Limitations. Limitations of the study include small
sample size and presenting retrospective data up to 2012—a
larger review of cases over the past ten years would assist in
clarifying the differences observed and allow for statistical
analysis. A number of patients had commenced antimi-
crobial therapy prior to presentation to hospital, which may
have impacted reported symptoms. Clinical presentation
and radiological and pathological findings vary depending
on the length of illness; our cohort was presented on a range
of number of days into illness.
5. Conclusion
Leptospirosis should be a differential diagnosis in patients
presenting with pyrexia, headache, and myalgia. Bio-
chemically, our results suggest that the most useful initial
markers to be raised are CRP and proteinuria on urinalysis.
+ese should be contextualised with identified risk factors
such as occupation and recreational activities, particularly
watersports. Previous literature on cases in New Zealand
suggests rash and conjunctival suffusion to be good
discriminators of disease, but this study did not find these
signs frequently present.
+is study has found that previous predictors of severe
leptospirosis do not predict any of the outcomes of ICU
admission, requirement for organ support, or length of
hospital stay. Although this study is not powered to find
predictors of outcome, it is clear that anicteric leptospirosis
is by no means a benign disease. Further larger studies are
required to confirm this difference in predicting the severity
of leptospirosis.
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